ZIOPHARM Oncology Net Income Quarterly:
-12.80M for March 31, 2013ZIOPHARM Oncology Historical Net Income Quarterly Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | -12.80M |
| Dec. 31, 2012 | -30.22M |
| Sept. 30, 2012 | -17.82M |
| June 30, 2012 | -23.61M |
| March 31, 2012 | -24.47M |
| Dec. 31, 2011 | -13.24M |
| Sept. 30, 2011 | -0.802M |
| June 30, 2011 | -10.72M |
| March 31, 2011 | -39.01M |
| Dec. 31, 2010 | -11.85M |
| Sept. 30, 2010 | -12.20M |
| June 30, 2010 | 9.039M |
| March 31, 2010 | -17.65M |
| Dec. 31, 2009 | 0.964M |
| Sept. 30, 2009 | -2.875M |
| June 30, 2009 | -2.399M |
| March 31, 2009 | -3.339M |
| Dec. 31, 2008 | -4.563M |
| Sept. 30, 2008 | -5.544M |
| June 30, 2008 | -6.501M |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Sept. 30, 2000 | Go Pro |
About Net Income
Net income is what remains of a company's revenue after subtracting all costs. It is also referred to as net profit, earnings, or the bottom line. Net Income that is not paid out in dividends is added to retained earnings.
Increasing (decreasing) net income is a good (bad) sign for a company's profitability. Companies with consistent and increasing net income over time are looked at very favorably by stockholders.
Learn More
ZIOP Net Income Quarterly Benchmarks
| Companies | |
|---|---|
| Threshold Pharmaceuticals | -9.214M |
| United Therapeutics Corporation | 62.32M |
| Omeros Corporation | -7.734M |
ZIOP Net Income Quarterly Rankings
| Overall |
34th percentile 4939 of 7590 |
| Sector |
13th percentile 566 of 651 in Healthcare |
| Industry |
20th percentile 189 of 238 in Biotechnology |
ZIOP Net Income Quarterly Range, Past 5 Years
| Minimum | -39.01M | Mar 2011 |
| Maximum | 9.039M | Jun 2010 |
| Average | -11.48M |
